← back to database
iGan Partners
HQ · Ontario
Seed to Series A investment in AI-enabled medtech, medical devices, diagnostics, medical imaging and digital health, primarily in Canada; follows on through exit and supports commercialization and scale-up.
Stage focus
Lead / follow
Specialization
Generalist / Specialist
Specialist
Investing team
- Sam IferganFounder & Managing Partner
- Dr. Lorena ToraChief Medical Officer
- Billy LaiVenture Partner
- Wendi ZhaoDirector, Investment & Portfolio Management
- David IferganAssociate
- Shira ReznikAnalyst
- Joel FinlaysonVenture Partner
- Anita NunesHR Office Manager
How to reach them
Notable investments
May 26, 2026: iGan announced its investment in Adenocyte, a pancreatic cancer early-detection medtech company. February 10, 2026: iGan led Exact Imaging’s $10M financing.
Sources
iganpartners.com ↗iganpartners.com/about-us ↗iganpartners.com/team ↗newswire.ca/news-releases/igan-partners-leads-10-million-financing-of-exact-imaging-the-world-s-leading-prostate-cancer-detection-platform-825117850.html ↗iganpartners.com/latest/igan-partners-invests-in-adenocyte-ltd-to-advance-the-early-detection-of-pancreatic-cancer ↗iganpartners.com ↗